Featured Articles
-
Earlier Disease Detection Study Utilizes EDC
5/15/2024
Leveraging hyperspectral imaging and AI-driven analysis, Optina Diagnostics aims to revolutionize Alzheimer's diagnosis, offering hope for earlier intervention and improved outcomes.
-
Measuring The True Patient Experience With ePRO
5/15/2024
Utilizing the insights covered in this article can inform the design and implementation of cancer trials, ultimately contributing to improved patient care and treatment outcomes.
-
ISR Report Sheds Light On eCOA/ePRO Market Dynamics
5/15/2024
This comprehensive overview highlights the critical role these platforms play in modern clinical research, emphasizing their impact on data integrity and trial efficiency.
-
Evaluating ‘Bother’ As A Component Of Patient-Reported Outcomes
5/15/2024
Learn how incorporating "bother" as a patient-reported outcome metric aligns research with real-world experiences and drug development with patient needs.
-
eConsent Readiness In 24 Countries
3/12/2024
Discover how regulatory bodies worldwide, including the U.S. Food and Drug Administration and the European Medicines Agency, are now championing the shift towards eConsent adoption.
-
The Place Of PROs In The Future Of Healthcare
3/12/2024
Discover how integrating Patient-Reported Outcomes can drive alignment with Value-Based Care (VBC) principles, enhancing product marketability and adoption while promoting patient health and quality of life.
-
Accelerating AI Innovation In Pharma: Collaboration Vs. Competition
3/12/2024
Learn how evolving with AI could potentially lead to more streamlined, efficient, and innovative drug development processes.
-
What FDA, EMA Discussion Papers Reveal About AI In Clinical Research
12/18/2023
Learn how having a comprehensive understanding of regulatory perspectives on AI ethics will prove invaluable for researchers evaluating the integration of AI technology into their trials.
-
10 FAQs On eConsent
11/16/2023
Closely examine the challenges of adoption, integration, and compliance measures involving eConsent and gain valuable insights for those contemplating their incorporation in clinical trials.
-
Preparing For Post-Market Clinical Follow-Up Under EU MDR
9/15/2023
Gain a better understanding of the primary challenges faced by the life sciences industry's commercial model in response to the updated EU MDR guidelines.